Essential Thrombocythemia
Detailed findings from SURPASS-ET including pharmacokinetic and biomarker data will be presented in the future.
Meta-analysis findings support the use of statins in patients with PV and ET to reduce mortality and thrombosis risk.
Pelabresib monotherapy appears to be clinically beneficial in patients who have high-risk essential thrombocythemia.
According to Ciro Roberto Rinaldi and collaborating researchers, CD47, but not calreticulin (CALR), was overexpressed on ...
Clinical and Prognostic Relevance of CALR Mutant Myeloproliferative Neoplasm in Pakistani Population
The findings of a study presented at the 12th International Congress on Myeloproliferative Neoplasms suggest performing ...
Researchers for a study presented at the 12th International Congress on Myeloproliferative Neoplasms used clinical data, ...
Advertisement
Expert Interviews on Hematology
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.